Director, Level 1 HDSA Center of Excellence, Vanderbilt University Medical Center
Daniel Claassen, MD, MS: Selective Knock-Downs in Huntington Disease
July 8th 2020The associate professor of neurology at Vanderbilt University Medical Center spoke to the findings of a recent study in Huntington disease that assessed the feasibility of selectively knocking down mutant protein expression.